Gail M Farfel Insider Trading $DRRX DURECT CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Gail M Farfel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Gail M Farfel. Gail M Farfel is Director in DURECT CORP ($DRRX) and Chief Clinical Dev & Reg Offic in MARINUS PHARMACEUTICALS INC ($MRNS) and EVP/Chief Development Officer in ZOGENIX, INC. ($ZGNX) and Director in AVROBIO, Inc. ($AVRO).

Gail M Farfel in DURECT CORP

Trading Symbol: DRRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gail M Farfel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 18 2020
$DRRX Market Capitalization: $139.97M
$DRRX Previous Close: $1.03

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Gail M Farfel in DURECT CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AVRO, DRRX, MRNS, ZGNX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 18 2020DRRXDURECT CORPFarfel Gail MDirectorOption ExerciseA2.3355,000128,15055,000
Jun 18 2020DRRXDURECT CORPFarfel Gail MDirectorOption ExerciseA2.3355,000128,15055,000
Apr 25 2019DRRXDURECT CORPFarfel Gail MDirectorOption ExerciseA0.5770,00039,78870,000

Page:   1